Literature DB >> 14580769

High levels of chromosomal imbalances in typical and small-cell variants of T-cell prolymphocytic leukemia.

Dolors Costa1, Rosa Queralt, Marta Aymerich, Ana Carrió, María Rozman, Teresa Vallespí, Dolors Colomer, Benet Nomdedeu, Emili Montserrat, Elías Campo.   

Abstract

T-cell prolymphocytic leukemia (T-PLL) is a rare postthymic T-cell disorder that may show different morphologic variants and a very aggressive clinical behavior. On occasion, patients may present with an indolent clinical course and long survival. The disease is genetically characterized by the presence of complex karyotypes with recurrent alterations involving chromosomes 8, 14, and 11. The possible relationship between genetic alterations and morphologic variants and the clinical course of the disease, however, is not well known. Comparative genomic hybridization (CGH) was used to detect chromosomal imbalances in eight patients diagnosed with T-PLL, including three cases of small-cell variant with an indolent clinical evolution. Abnormal profiles were detected in all cases. The chromosomal regions most often over-represented were 8q (75%), 5p (62%), and 14q (37%), as well as 6p and 21 (both 25%). The chromosomal regions most often underrepresented were 8p and 11q (75%), 13q (37%), and 6q, 7q, 16q, 17p, and 17q (25%). The number of chromosomal imbalances in the three small-cell variants was relatively similar to that of cases with typical morphology. Only gains of 6p and losses of 7q present in three and two cases, respectively, with typical morphology were not detected in any small-cell variant. CGH analysis revealed alterations in 15 chromosomal regions not detected by conventional cytogenetics. These results indicate that T-PLL carry a high number of chromosomal alterations that are not related to the morphologic variants or the clinical behavior of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580769     DOI: 10.1016/s0165-4608(03)00161-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

1.  T-cell prolymphocytic leukemia in Japan: is it a variant?

Authors:  Junichi Kameoka; Naoto Takahashi; Hideyoshi Noji; Kazunori Murai; Katsushi Tajima; Yoshihiro Kameoka; Shinji Sato; Tsutomu Shichishima; Yoji Ishida; Hideo Harigae; Kenichi Sawada
Journal:  Int J Hematol       Date:  2012-04-24       Impact factor: 2.490

Review 2.  Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.

Authors:  Philipp B Staber; Marco Herling; Mar Bellido; Eric D Jacobsen; Matthew S Davids; Tapan Mahendra Kadia; Andrei Shustov; Olivier Tournilhac; Emmanuel Bachy; Francesco Zaja; Kimmo Porkka; Gregor Hoermann; Ingrid Simonitsch-Klupp; Claudia Haferlach; Stefan Kubicek; Marius E Mayerhoefer; Georg Hopfinger; Ulrich Jaeger; Claire Dearden
Journal:  Blood       Date:  2019-07-10       Impact factor: 22.113

Review 3.  Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.

Authors:  Aude Collignon; Anne Wanquet; Elsa Maitre; Edouard Cornet; Xavier Troussard; Thérèse Aurran-Schleinitz
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

4.  Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.

Authors:  Mark J Kiel; Thirunavukkarasu Velusamy; Delphine Rolland; Anagh A Sahasrabuddhe; Fuzon Chung; Nathanael G Bailey; Alexandra Schrader; Bo Li; Jun Z Li; Ayse B Ozel; Bryan L Betz; Roberto N Miranda; L Jeffrey Medeiros; Lili Zhao; Marco Herling; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  Blood       Date:  2014-05-13       Impact factor: 22.113

5.  Do novo del(9)(p13) in a childhood T-cell prolymphocytic leukemia as sole abnormality.

Authors:  Abdulsamad Wafa; Abdulmunim Aljapawe; Moneeb Ak Othman; Thomas Liehr; Eyad Alhourani; Walid Al Achkar
Journal:  Exp Hematol Oncol       Date:  2014-11-25

Review 6.  Mature T-Cell leukemias: Challenges in Diagnosis.

Authors:  Dima El-Sharkawi; Ayoma Attygalle; Claire Dearden
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

7.  "T-cell prolymphocytic leukemia (T-PLL), a heterogeneous disease exemplified by two cases and the important role of cytogenetics: a multidisciplinary approach".

Authors:  Carlos A Tirado; Phillip Starshak; Paul Delgado; Nagesh Rao
Journal:  Exp Hematol Oncol       Date:  2012-08-20

8.  Pediatric T-cell prolymphocytic leukemia with an isolated 12(p13) deletion and aberrant CD117 expression.

Authors:  Michael Bellone; Annika M Svensson; Ann-Leslie Zaslav; Silvia Spitzer; Marc Golightly; Mahmut Celiker; Youjun Hu; Yupo Ma; Tahmeena Ahmed
Journal:  Exp Hematol Oncol       Date:  2012-04-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.